Awareness of Obesity and Weight Issues Among Chronically Mentally 111 Inpatients: A Pilot Study

References

• Devlin MJ, Yanovski SZ, Wilson GT: Obesity: What men-tal health professionals need to know [see comments]. Am J Psychiatry 2000; 157:854–866
   PubMed Web of Science ®Google Scholar
• Wetterling T: Bodyweight gain with atypical antipsychotics. A comparative review. Drug Saf 2001; 24:59–73
   PubMed Web of Science ®Google Scholar
• Meyer JM: A retrospective comparison of lipid, glucose and weight changes at one year between olanzapine and risperi-done treated inpatients. J Clin Psychiatry in press
   Google Scholar
• Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, Weiden PJ, Cheskin II: The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60:215–220
   PubMed Web of Science ®Google Scholar
• Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, Weiden PJ: Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 1999; 156:1686–1696
   PubMed Web of Science ®Google Scholar
• Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM: Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000; 283:506–511
   PubMed Web of Science ®Google Scholar
• Osby U, Correia N, Brandt L, Ekbom A, Sparen P: Mortality and causes of death in schizophrenia in Stockholm County, Sweden. Schizophr Res 2000; 45:21–28
   PubMed Web of Science ®Google Scholar
• Flegal KM, Troiano RP: Changes in the distribution of body mass index of adults and children in the US population. Intl J Obes Relat Metab Disord 2000; 24:807–818
   PubMed Web of Science ®Google Scholar
• Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obe-sity. JAMA 1999; 282:1523–1529
   PubMed Web of Science ®Google Scholar
• Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA: Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 2001; 161:1581–1586
   PubMed Web of Science ®Google Scholar
• Colditz GA: Economic costs of obesity and inactivity. Med Sci Sports Exerc 1999; 31:S663–S667
   PubMed Web of Science ®Google Scholar
• Dixon L. Postrado L, Delahanty J, Fischer PJ, Lehman A: The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis 1999; 187:496–502
   PubMed Web of Science ®Google Scholar
• Brown S, Inskip H, Barraclough B: Causes of the excess mor-tality of schizophrenia. Br J Psychiatry 2000; 177:212–217
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW, Meise U, Gunther V, Kurz M: Compliance with antipsychotic drug treatment: Influence of side effects. Acta Psychiatrica Scand Suppl 1994; 382:11–15
   PubMedGoogle Scholar
• Tsuang MT, Perkins K, Simpson JC: Physical diseases in schizophrenia and affective disorder. J Clin Psychiatry 1983; 44:42–46
   PubMed Web of Science ®Google Scholar
• Harris EC, Barraclough B: Excess mortality of mental disor-der. Br .1 Psychiatry 1998; 173:11–53
   PubMed Web of Science ®Google Scholar
• Goldman LS: Medical illness in patients with schizophrenia. J Clin Psychiatry 1999; 60:10–15
   PubMed Web of Science ®Google Scholar
• Cramer JA, Rosenheck R, Xu W, Thomas J, Henderson W, Charney DS: Quality of life in schizophrenia: A comparison of instruments. Department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. Schizophr Bull 2000; 26:659–666
   Google Scholar
• Druss B, Rohrbaugh RM, Levinson CM, Rosenheck RA: Inte-grated medical care for patients with serious psychiatric illness: A randomized trial. Arch Gen Psychiatry 2001; 58:861–868
   PubMed Web of Science ®Google Scholar
• Eder U, Mangweth B, Ebenbichler C, Weiss E, Hofer A, Hummer M, Kemmler G, Lechleitner M, Fleischhacker WW: Association of olanzapine-induced weight gain with an in-crease in body fat. Am J Psychiatry 2001; 158:1719–1722
   PubMedGoogle Scholar
• Kurzthaler I, Fleischhacker WW: The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 2001; 62:32–37
   PubMed Web of Science ®Google Scholar
• Russell JM, Mackel JA: Bodyweight gain associated with atypi-cal antipsychotics: Epidemiology and therapeutic implications. CNS Drugs 2001; 15:537–551
   PubMed Web of Science ®Google Scholar
• Sussman N: Review of atypical antipsychotics and weight gain. J Clin Psychiatry 2001; 62:5–12
   PubMedGoogle Scholar
• Wetterling T: Bodyweight gain with atypical antipsychotics. A comparative review. Drug Saf 2001; 24:59–73
   PubMed Web of Science ®Google Scholar
• Sletten I, Cazenave M, Gershon S: Effects of caloric restriction on behavior and body weight during chlorpromazine therapy. Dis Nerv Syst 1967; 28:519–522
   PubMedGoogle Scholar
• Sletten IW, Ognjanov V, Menendez S, Sundland D, el-Toumi A: Weight reduction with chlorphenetermine and phenmetrazine in obese psychiatric patients during chlorpromazine therapy. Curr Ther Res Clin Exp 1967; 9:570–575
   PubMed Web of Science ®Google Scholar
• Harmatz MG, Lapuc P: Behavior modification of overeating in a psychiatric population. J Consult Clin Psychol 1968; 32:583–587
   PubMed Web of Science ®Google Scholar
• Klein B, Simon WE, Steele RL, Primavera LH: Reinforcement and weight loss in schizophrenics. Psychol Rep 1972; 30:581–582
   Google Scholar
• Knox JM: A study of weight reducing diets in psychiatric in-patients. Br J Psychiatry 1980; 136:287–289
   PubMed Web of Science ®Google Scholar
• Rotatori AF, Fox R, Wicks A: Weight loss with psychiatric residents in a behavioral self control program. Psycho] Rep 1980; 46:483–486
   PubMed Web of Science ®Google Scholar
• Svacina S, Sonka J, Marek J: Dexfenfluramine in psychotic patients. Int J Eat Disord 1998; 24:335–338
   Google Scholar
• Umbricht D, Flury H, Bridler R: Cognitive behavior therapy for weight gain. Am J Psychiatry 2001; 158:971
   PubMed Web of Science ®Google Scholar
• Ball MP, Coons VB, Buchanan RW: A program for treating olanzapine-related weight gain. Psychiatric Serv 2001; 52:967–969
   PubMed Web of Science ®Google Scholar
• Cachelin FM, Striegel-Moore RH, Elder KA: Realistic weight perception and body size assessment in a racially diverse com-munity sample of dieters. Obes Res 1998; 6:62–68
   PubMedGoogle Scholar
• Rasheed P: Perception of body weight and self-reported eatingand exercise behaviour among obese and non-obese women in Saudi Arabia. Public Health 1998; 112:409–414
   PubMed Web of Science ®Google Scholar
• Crawford D, Campbell K: Lay definitions of ideal weight and overweight. Int J Obes Relat Metab Disord 1999; 23:738–745
   PubMed Web of Science ®Google Scholar
• Neumark-Sztainer D: The weight dilemma: A range of philo-sophical perspectives. Int J Obes Relat Metab Disord 1999; 23:S31–S37
   Google Scholar
• Lowry R, Galuska DA, Fulton JE, Wechsler H, Kann L, Collins JL: Physical activity, food choice, and weight management goals and practices among us college students. Am J Prey Med 2000; 18:18–27
   PubMed Web of Science ®Google Scholar
• Girois SB, Kumanyika SK, Morabia A, Mauger E: A compar-ison of knowledge and attitudes about diet and health among 35- to 75-year-old adults in the United States and Geneva, Switzerland. Am J Public Health 2001; 91:418–424
   PubMedGoogle Scholar
• Wardle J, Rapoport L, Miles A, Afuape T, Duman M: Mass ed-ucation for obesity prevention: The penetration of the BBC's 'fighting fat, fighting fit' campaign. Health Educ Res 2001; 16:343–355
   PubMed Web of Science ®Google Scholar
• Lohr JB, Flynn K: Smoking and schizophrenia. Schizophr Res 1992; 8:93–102
   PubMed Web of Science ®Google Scholar
• de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM: Schizophrenia and smoking: An epidemiologi-cal survey in a state hospital. Am J Psychiatry 1995; 152:453–455
   PubMed Web of Science ®Google Scholar
• Pearlman T: Impact of a smoking ban on a locked psychiatric unit [letter; comment]. J Clin Psychiatry 1997; 58:179
   Google Scholar
• Longo DR, Feldman MM, Kruse RL, Brownson RC, Petroski, GF, Hewett JE: Implementing smoking bans in American hospitals: Results of a national survey. Tob Control 1998; 7: 47–55
   PubMed Web of Science ®Google Scholar
• Lyon ER: A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatric Serv 1999; 50:1346–1350
   PubMed Web of Science ®Google Scholar
• Meyer JM: Individual changes in clozapine levels after smoking cessation: Results and a predictive model. J Clin Psychopharmacol 2001; 21:569–74
   Google Scholar